Evidence map›Paper›PMID 39402509›Full record

ArticleBMC pulmonary medicine2024

The severity assessment and nucleic acid turning-negative-time prediction in COVID-19 patients with COPD using a fused deep learning model.

Yanhui Liu, Wenxiu Zhang, Mengzhou Sun, Xiaoyun Liang, Lu Wang, Jiaqi Zhao, Yongquan Hou, Haina Li, Xiaoguang Yang

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanhui Liu *Medical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.
Wenxiu Zhang *Institute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd, Shanghai, P.R. China.
Mengzhou SunInstitute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd, Beijing, P.R. China.
Xiaoyun LiangInstitute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd, Shanghai, P.R. China.
Lu WangMedical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.
Jiaqi ZhaoMedical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.
Yongquan HouRespiratory and Critical Care Medicine Department, Hohhot First Hospital, Inner Mongolia, P.R. China.
Haina LiMedical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.
Xiaoguang YangMedical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China. 13347113579@163.com.

Funding

the Inner Mongolia Autonomous Region Science and Technology Plan Project 2023YFSH0015
6 · The paper itself

Abstract

backgroundPrevious studies have shown that patients with pre-existing chronic obstructive pulmonary diseases (COPD) were more likely to be infected with coronavirus disease (COVID-19) and lead to more severe lung lesions. However, few studies have explored the severity and prognosis of COVID-19 patients with different phenotypes of COPD. PURPOSE: The aim of this study is to investigate the value of the deep learning and radiomics features for the severity evaluation and the nucleic acid turning-negative time prediction in COVID-19 patients with COPD including two phenotypes of chronic bronchitis predominant patients and emphysema predominant patients.

methodsA total of 281 patients were retrospectively collected from Hohhot First Hospital between October 2022 and January 2023. They were divided to three groups: COVID-19 group of 95 patients, COVID-19 with emphysema group of 94 patients, COVID-19 with chronic bronchitis group of 92 patients. All patients underwent chest computed tomography (CT) scans and recorded clinical data. The U-net model was pretrained to segment the pulmonary involvement area on CT images and the severity of pneumonia were evaluated by the percentage of pulmonary involvement volume to lung volume. The 107 radiomics features were extracted by pyradiomics package. The Spearman method was employed to analyze the correlation of the data and visualize it through a heatmap. Then we establish a deep learning model (model 1) and a fusion model (model 2) combined deep learning with radiomics features to predict nucleic acid turning-negative time.

resultsCOVID-19 patients with emphysema was lowest in the lymphocyte count compared to COVID-19 patients and COVID-19 companied with chronic bronchitis, and they have the most extensive range of pulmonary inflammation. The lymphocyte count was significantly correlated with pulmonary involvement and the time for nucleic acid turning negative (r=-0.145, P < 0.05). Importantly, our results demonstrated that model 2 achieved an accuracy of 80.9% in predicting nucleic acid turning-negative time.

conclusionThe pre-existing emphysema phenotype of COPD severely aggravated the pulmonary involvement of COVID-19 patients. Deep learning and radiomics features may provide more information to accurately predict the nucleic acid turning-negative time, which is expected to play an important role in clinical practice.

Indexed as

COVID-19Deep LearningPulmonary Disease, Chronic ObstructiveSARS-CoV-2Severity of Illness IndexTomography, X-Ray ComputedAgedFemaleHumansLungMaleMiddle AgedPrognosisPulmonary EmphysemaRetrospective StudiesCOVID-19 with COPDDeep learning methodNucleic acid turning-negative timePulmonary involvementRadiomics features

Identifiers

PMID39402509
PMCPMC11476205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.